Imed Infinity Medical-Limited Partnership
Imed Infinity Medical-Limited Partnership, a research and development partnership, focuses on investing in research projects and development in the medical field, primarily the digital health field. Imed Infinity Medical-Limited Partnership was incorporated in 2020 and is based in Tel Aviv, Israel.
Imed Infinity Medical-Limited Partnership (IMED) - Total Liabilities
Latest total liabilities as of June 2025: ILA165.00K ILA
Based on the latest financial reports, Imed Infinity Medical-Limited Partnership (IMED) has total liabilities worth ILA165.00K ILA as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Imed Infinity Medical-Limited Partnership - Total Liabilities Trend (2020–2024)
This chart illustrates how Imed Infinity Medical-Limited Partnership's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Imed Infinity Medical-Limited Partnership Competitors by Total Liabilities
The table below lists competitors of Imed Infinity Medical-Limited Partnership ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
XINYI GLASS HLDGS (XI9.SG)
STU:XI9
|
Germany | €14.95 Billion |
|
Global Gaming Technologies Corp
PINK:BLKCF
|
USA | $5.75 Million |
|
Genesis Healthcare Inc
PINK:GENN
|
USA | $4.04 Billion |
|
UR-ENERGY
MU:U9T
|
Germany | €48.46 Million |
Liability Composition Analysis (2020–2024)
This chart breaks down Imed Infinity Medical-Limited Partnership's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 23.81 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.02 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.02 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Imed Infinity Medical-Limited Partnership's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Imed Infinity Medical-Limited Partnership (2020–2024)
The table below shows the annual total liabilities of Imed Infinity Medical-Limited Partnership from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ILA112.00K | -21.13% |
| 2023-12-31 | ILA142.00K | +2.16% |
| 2022-12-31 | ILA139.00K | -20.57% |
| 2021-12-31 | ILA175.00K | +59.09% |
| 2020-12-31 | ILA110.00K | -- |